Tag: COVID-19
‘Insurance Claims: Legal and Practical Tips in a Transitioning Market’ – Recorded Webcast
Sam Tacey, special counsel in Cooley’s Insurance & Reinsurance team, recently presented on insurance claims issues on a Marsh hosted webinar. The full webcast is available to be viewed here. Sam’s presentation addresses 4 key areas (i) Settlement of Underlying Claims (ii) Cover for defence costs (iii) Notice provisions (iv) […]
European Commission Publishes 2020 Product Safety Review
COVID-19 shifts the focus of product safety reports in Europe, but the usual trends continue.
UK’s medicines and medical devices regulator to tackle Brexit, technological advancements and regulatory challenges (including from COVID-19) in 2020 and 2021
Sarah-Jane Dobson and Amal Ali
The MHRA has established five strategic goals for 2020-21 that will impact all those operating in the UK medicines and medical devices industries
Flexibility for our furry friends
Sarah-Jane Dobson and Olivia Flasch
EU regulators have taken steps to address supply chain disruption and increased demand in veterinary medicines caused by the COVID-19 pandemic.
Insurance: Not Much of a Muchness
Many policyholders believe that the insurance available on the market covering a particular type of risk is much of a muchness. The disputes about insurance cover for business interruption losses due to COVID-19 have highlighted that this assumption is misconceived. Insurance policies are not commoditised. There are no standard forms […]
EU adjusted 2020 Work Programme: product safety and consumer rights remain on the agenda
The European Commission published its adjusted Work Programme for 2020, following the impact of the COVID-19 pandemic. Product safety and consumer law initiatives remain very much on the Commission’s agenda. However, some timelines have been extended and stakeholders will be given additional time to contribute to consultations to help shape future policy and law in these areas.
COVID-19: Weekly Life Sciences Digest – Testing Kits for COVID-19
Natasha Leskovsek, Andrew Barr, Sarah-Jane Dobson, Edward Turtle, Harriet Jones and Julia Maskell
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
UK-specific guidance for the application and management of clinical trials in the context of COVID-19
Sarah-Jane Dobson and Amal Ali
The UK’s MHRA has stated it will be particularly flexible and pragmatic in authorising clinical trials connected to COVID-19, referring to its previous track record of having acted swiftly in past public health crises
WEBCAST: Products & Consumer Rights: Global Hot Topics
Cooley’s international products law team is pleased to announce the third event in its webcast series looking at the latest consumer rights issues product manufacturers, suppliers and other stakeholders are facing in the rapidly changing global environment. This time we will be joined by Wendy Hederman, a partner at leading Irish law […]
2020 Vision – Looking Beyond COVID-19: Longer-Term Considerations for Supply and Manufacture of Products During COVID-19
Sarah-Jane Dobson, Andrew Barr and Richard Hopley
With COVID-19 causing a pivot or volume increase in production, companies should pause to reflect on the longer-term considerations in terms of international product safety, liability and insurance law issues.